3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Lung Neoplasms
3
Colorectal Neoplasms
3
Oropharyngeal Neoplasms
2
Neoplastic Cells, Circulating
2
Cholangiocarcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Recurrence
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm, Residual
1
Hematopoietic and Lymphoid System Neoplasm
1
Gallbladder Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Carcinoma, Lobular
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
90
Blood Specimen Collection
41
Cyclophosphamide
37
Bevacizumab
36
Nivolumab
35
Standard of Care
32
Carboplatin
31
Surveys and Questionnaires
29
Paclitaxel
27
atezolizumab
25
Exercise
25
Pemetrexed
24
Gemcitabine
23
Cisplatin
23
Fluorouracil
22
Radiotherapy
20
Leucovorin
20
Dexamethasone
20
Docetaxel
19
Oxaliplatin
18
Rituximab
16
Irinotecan
16
Cetuximab
16
dostarlimab
15
Drug Therapy
15
Doxorubicin
15
Ipilimumab
14
Biopsy
14
130-nm albumin-bound paclitaxel
14
fludarabine
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
Liquid Biopsy
×
1 year
×
Clear all
No trials found.